← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2007Last known activity
Dec 15, 2025
Timeline
1950s
- Jun 1, 1958
Hubei University of Chinese Medicine— Founded
Drugs by trial phase (28 distinct, 20 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Cerebral Infarction
- Communicable Diseases
- Constipation
- Diabetes Mellitus
- Diabetic Nephropathies
- Fibrosis
- Hepatitis
- Hepatitis A
- Hepatitis B
- Infections
- Ischemia
- Kidney Diseases
- Liver Cirrhosis
- Musculoskeletal Diseases
- Osteoarthritis
- Osteoarthritis, Knee
- Pneumonia
- Polyneuropathies
- Pulmonary Fibrosis
- Retinal Diseases
- Stroke
- Urinary Tract Infections
Recent trials (22)
- NCT07240467CollaboratorPhase 2/Phase 3Dec 15, 2025
- NCT04906083CollaboratorPhase 4Feb 1, 2021
- NCT04582942CollaboratorN/AAug 6, 2020
- NCT04310865Overall official - principal investigatorPhase 2/Phase 3Mar 20, 2020
- NCT04278963Overall official - principal investigatorPhase 2/Phase 3Feb 27, 2020
- NCT04279197CollaboratorPhase 2Feb 15, 2020
- NCT04645407CollaboratorPhase 4Feb 1, 2020
- NCT04150835CollaboratorPhase 4Nov 30, 2019
- NCT05535179Lead sponsorPhase 2Apr 1, 2019
- NCT05535179Reponsible party - principal investigatorPhase 2Apr 1, 2019
- NCT03658291CollaboratorPhase 4Sep 1, 2018
- NCT03577938CollaboratorN/ASep 1, 2018
- NCT03577938Overall official - principal investigatorN/ASep 1, 2018
- NCT03309501CollaboratorPhase 3Sep 12, 2017
- NCT03025399CollaboratorEarly Phase 1Feb 1, 2017
Details
- Founded
- Wuhan City, CN Jun 1, 1958
- Last known activity
- Dec 15, 2025